Ivermectin effect in treatment of patients with human fascioliasis
Phase 2
- Conditions
- Fasciola.Infection due to Fasciola
- Registration Number
- IRCT201105291155N13
- Lead Sponsor
- Vince chancellor for reaserch Guilan univercity of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
persons are over 18 years old with human fascioliasis
Exclusion criteria: pregnancy;lactation;hypersensitivy to the drug
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ivermectin effect in treatment of patients with Fascioliasis. Timepoint: 1 month and 3 months after treatment. Method of measurement: negative ELISA- negative S/E-absence of hypereosinophilia-recovery of patients signs.
- Secondary Outcome Measures
Name Time Method